Pharming Group N.V. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PHAR Nasdaq 2836 www.pharming.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Pharming Group N.V.

Pharming announces CEO transition - Sep 28th, 2026 11:00 pm
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS - Sep 25th, 2026 8:30 am
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026 - Sep 21st, 2026 11:00 pm
Pharming Group (PHAR) Expands Joenja’s Pediatric Label. Can Growth Offset RUCONEST Weakness? - Sep 16th, 2026 4:44 pm
FDA approves Pharming's Joenja® as first treatment for children with APDS in the U.S. - Sep 11th, 2026 12:00 pm
Pharming Group to participate in September investor conferences - Sep 9th, 2026 12:00 am
Form 8.3 - Aug 14th, 2026 4:36 am
Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older - Aug 12th, 2026 11:00 pm
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference - Aug 4th, 2026 12:00 am
Pharming Group (ENXTAM:PHARM) Could Be 63% Undervalued After Guidance Cut And Half Year Results - Aug 2nd, 2026 6:15 pm
Pharming Group (PHGUF) (Q2 2026) Earnings Call Highlights: Joenja Surges 40% as Ruconest Faces ... - Jul 30th, 2026 1:04 pm
Pharming Group Q2 Earnings Call Highlights - Jul 30th, 2026 7:04 am
Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use - Jul 29th, 2026 11:00 pm
Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30 - Jul 16th, 2026 12:00 am
Pharming Group (ENXTAM:PHARM) Stock Gets Fair Value Boost As Joenja Progress Supports Growth Case - Jun 27th, 2026 7:08 am
DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock? - Jun 15th, 2026 5:59 am